Blueprint Investment Partners’s Pfizer PFE Stock Holding History

Blueprint Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Sell	10,259 -9,910	-49%	-$259K	0.02%	155
2026 Q1	$566K	Buy	20,169 +4,250	+27%	+$113K	0.06%	110
2025 Q4	$396K	Buy	+15,919	New	+$401K	0.04%	117
2024 Q4	–	Sell	-8,444	Closed	-$244K	–	210
2024 Q3	$244K	Buy	+8,444	New	+$246K	0.04%	150
2023 Q1	–	Sell	-18,983	Closed	-$973K	–	271
2022 Q4	$973K	Buy	+18,983	New	+$910K	0.21%	81
2022 Q3	–	Sell	-25,869	Closed	-$1.36M	–	179
2022 Q2	$1.36M	Buy	25,869 +12,745	+97%	+$649K	0.37%	47
2022 Q1	$679K	Sell	13,124 -841	-6%	-$43.6K	0.17%	85
2021 Q4	$825K	Buy	13,965 +5,239	+60%	+$260K	0.2%	89
2021 Q3	$375K	Buy	+8,726	New	+$387K	0.19%	81

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blueprint Investment Partners's PFE Position: Q2 2026 in Review

Blueprint Investment Partners reduced its Pfizer (PFE) stake by 49% in Q2 2026, selling an estimated $259K and leaving 10,259 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #155.

Blueprint Investment Partners first reported a position in PFE in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.36M in Q2 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Blueprint Investment Partners held 10,259 shares of Pfizer worth $247K as of Q2 2026.
Blueprint Investment Partners sold 9,910 Pfizer shares in Q2 2026, an estimated $259K.
Pfizer made up 0.02% of Blueprint Investment Partners's portfolio in Q2 2026, its #155 holding.
Blueprint Investment Partners first reported a position in Pfizer in Q3 2021 and has held it in 9 quarters since.
Blueprint Investment Partners's Pfizer position peaked at $1.36M in Q2 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blueprint Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.